Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn's Disease Compared With Reactive Monitoring.
Assa A, Matar M, Turner D, Broide E, Weiss B, Ledder O, Guz-Mark A, Rinawi F, Cohen S, Topf-Olivestone C, Shaoul R, Yerushalmi B, Shamir R. Assa A, et al. Gastroenterology. 2019 Oct;157(4):985-996.e2. doi: 10.1053/j.gastro.2019.06.003. Epub 2019 Jun 10. Gastroenterology. 2019. PMID: 31194979 Clinical Trial.
Combination Therapy of Adalimumab With an Immunomodulator Is Not More Effective Than Adalimumab Monotherapy in Children With Crohn's Disease: A Post Hoc Analysis of the PAILOT Randomized Controlled Trial.
Matar M, Shamir R, Turner D, Broide E, Weiss B, Ledder O, Guz-Mark A, Rinawi F, Cohen S, Topf-Olivestone C, Shaoul R, Yerushalmi B, Ben-Horin S, Assa A. Matar M, et al. Inflamm Bowel Dis. 2020 Oct 23;26(11):1627-1635. doi: 10.1093/ibd/izz294. Inflamm Bowel Dis. 2020. PMID: 31793630 Clinical Trial.
The Effect of Adalimumab Treatment on Linear Growth in Children With Crohn Disease: A Post-hoc Analysis of the PAILOT Randomized Control Trial.
Matar M, Shamir R, Lev-Zion R, Broide E, Weiss B, Ledder O, Guz-Mark A, Rinawi F, Cohen S, Topf-Olivestone C, Shaoul R, Yerushalmi B, Assa A. Matar M, et al. J Pediatr Gastroenterol Nutr. 2020 Aug;71(2):237-242. doi: 10.1097/MPG.0000000000002728. J Pediatr Gastroenterol Nutr. 2020. PMID: 32324651 Clinical Trial.
Outcomes Following Pouch Formation in Paediatric Ulcerative Colitis: A Study From the Porto Group of ESPGHAN.
Orlanski-Meyer E, Topf-Olivestone C, Ledder O, Dotan I, Folmer-Hansen L, Kindermann A, Assa A, Kolho KL, Kolaček S, Carroll MW, Strisciuglio C, Aloi M, Hansen R, Navon D, Winter HS, Navas-López VM, de Ridder L, Smets F, Weiss B, Turner D. Orlanski-Meyer E, et al. J Pediatr Gastroenterol Nutr. 2020 Sep;71(3):346-353. doi: 10.1097/MPG.0000000000002805. J Pediatr Gastroenterol Nutr. 2020. PMID: 32541197 Free article.
Mucus sialylation determines intestinal host-commensal homeostasis.
Yao Y, Kim G, Shafer S, Chen Z, Kubo S, Ji Y, Luo J, Yang W, Perner SP, Kanellopoulou C, Park AY, Jiang P, Li J, Baris S, Aydiner EK, Ertem D, Mulder DJ, Warner N, Griffiths AM, Topf-Olivestone C, Kori M, Werner L, Ouahed J, Field M, Liu C, Schwarz B, Bosio CM, Ganesan S, Song J, Urlaub H, Oellerich T, Malaker SA, Zheng L, Bertozzi CR, Zhang Y, Matthews H, Montgomery W, Shih HY, Jiang J, Jones M, Baras A, Shuldiner A, Gonzaga-Jauregui C, Snapper SB, Muise AM, Shouval DS, Ozen A, Pan KT, Wu C, Lenardo MJ. Yao Y, et al. Among authors: topf olivestone c. Cell. 2022 Mar 31;185(7):1172-1188.e28. doi: 10.1016/j.cell.2022.02.013. Epub 2022 Mar 17. Cell. 2022. PMID: 35303419 Free PMC article.
Characterization and Short-Term Outcome of Potential Celiac Disease in Children.
Kori M, Topf-Olivestone C, Rinawi F, Lev-Tzion R, Ziv-Sokolovskaya N, Lapidot Alon N, Guz-Mark A, Shamir R. Kori M, et al. Among authors: topf olivestone c. Medicina (Kaunas). 2023 Jun 21;59(7):1182. doi: 10.3390/medicina59071182. Medicina (Kaunas). 2023. PMID: 37511994 Free PMC article.
15 results